ESCATEC Details CEO Transition: People in the News: 12/6/23

Integrated electronics manufacturing services provider and MOEMS manufacturer ESCATEC Group named Charles-Alexandre Albin CEO. Albin, son of ESCATEC founder Christophe Albin, has been with the company since 2013. He has served in various roles as a board member, executive director, leader of mergers and acquisitions, and chief sales officer.

Charles-Alexandre Albin. Courtesy of ESCATEC.

ANDOVER, Mass. — MKS Instruments CFO Seth H. Bagshaw will retire from the company. Holding the positions of executive vice president and treasurer along with CFO, Bagshaw joined MKS in 2006. Bagshaw also held the positions of senior vice president, vice president, and corporate controller during his time with MKS.

CAMBRIDGE, Mass. — Vizgen, a life sciences company focusing on visualizing single-cell spatial genomics information, appointed Seth Benson CFO and Sara Mackey vice president of marketing. Benson has over 20 years of experience in finance, strategy, and operations holding various leadership roles at high-growth life sciences companies and commercial labs, including Akoya Biosciences. Mackey formerly served as vice president of biopharma and corporate strategy at Advanced Instruments.

David De Craemer. Courtesy of STL.

MUMBAI, India — Optical and digital solutions company STL named David De Craemer business head and Tomasz Bednarczyk global R&D head for optical connectivity. De Craemer has 25 years of industry experience, including with TE Connectivity and CommScope. Prior to STL, Bednarczyk worked for 18 years at Corning in various roles.

Robert L. Huffines. Courtesy of Eikon Therapeutics.

HAYWARD, Calif. — Biotech company Eikon Therapeutics appointed Robert Huffines independent director. Huffines serves as global chairman of investment banking at J.P. Morgan Chase, specializing in guiding life science companies through complex financial landscapes. He is also a member of the board of Nextech Invest Ltd., a cancer-focused venture capital firm headquartered in Zurich.

WESTON, Mass. — Aquyre Biosciences appointed Gregory Bowles president, CEO, and a member of the board of directors. The appointments comes as Aquyre develops its Van Gogh phase-contrast microscope system. Bowles has over 20 years of experience in the medical technologies industry, including capital sales manager for Intuitive Surgical.